Cholic Acid

CHEMBL205596 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
408.6 g/mol
LogP
3.6
Phase
4

A primary bile acid that facilitates the absorption of dietary fats and fat-soluble vitamins in the small intestine by emulsifying lipid droplets. It is used therapeutically to treat inborn errors of bile acid synthesis, rare metabolic disorders that impair the body's ability to produce bile acids naturally. Oral replacement with cholic acid helps restore normal bile flow and prevents progressive liver damage.

الوزن الجزيئي

408,6000 g/mol

LogP

3,60

TPSA

98,00 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

آلية العمل

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

InChI

InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1

Molecular Formula

C24H40O5

HBD / HBA

4 / 5

الروابط القابلة للدوران

4

الذرات الثقيلة

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A primary bile acid that facilitates the absorption of dietary fats and fat-soluble vitamins in the small intestine by emulsifying lipid droplets. It is used therapeutically to treat inborn errors of bile acid synthesis, rare metabolic disorders that impair the body's ability to produce bile acids naturally. Oral replacement with cholic acid helps restore normal bile flow and prevents progressive liver damage.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Cholic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL205596. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 221493. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.